Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
about
Improved dissolution and anti-inflammatory activity of ibuprofen-polyethylene glycol 8000 solid dispersion systemsFormulation of immediate release pellets containing famotidine solid dispersionsSolid Dispersion Approach Improving Dissolution Rate of Stiripentol: a Novel Antiepileptic Drug.Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.Physicochemical characterization and dissolution properties of meloxicam-gelucire 50/13 binary systems.Investigation on in vitro dissolution rate enhancement of indomethacin by using a novel carrier sucrose fatty acid esterFormulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancerEnhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs.3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.Design and characterization of cefuroxime axetil biphasic floating minitablets.Synthesis of a novel pH responsive phyllosilicate loaded polymeric hydrogel based on poly(acrylic acid-co-N-vinylpyrrolidone) and polyethylene glycol for drug delivery: modelling and kinetics study for the sustained release of an antibiotic drug
P2860
Q28829654-0CAB9C73-B64F-4BBA-8088-194B1FE58BFBQ35125581-30EE35C2-B698-41B1-AA3C-066A81BA6A73Q35868089-15216FDA-E6EE-4A2D-B359-A3B89C151C72Q41961437-FF1A1D88-3063-4E5B-8A1D-E58F9751ED05Q41993975-5064FB57-4644-4DE0-B16B-2BE895D11762Q42387875-62A6FBC3-E518-478A-8882-263264387EF3Q42414128-D93E8BE1-3AB4-4B5B-8F70-AEBABA43AEDAQ44723040-F6029BB4-7776-43CB-80E7-69A252D8E4A6Q46792538-12EA5D44-DC8B-44A7-9E53-82C4009EB927Q48170489-256F604F-1C43-4044-8553-F9C59EF9A95DQ48185685-3124F7FF-0E18-42B7-B5EC-3A61F96E285CQ50887645-B101DB01-92C5-4265-BF60-951F024F0022Q53547529-660C7518-06BF-48BC-88F7-2CDBDE536D0CQ54297056-977795F5-992A-49AC-93B7-A178CC6A9327Q57376858-C4AD348F-BEAE-480E-9578-63ED735F6B4F
P2860
Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@en
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@nl
type
label
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@en
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@nl
prefLabel
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@en
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@nl
P2093
P2860
P1476
Improvement of solubility and ...... in Gelucire 50/13 and PEG4000.
@en
P2093
Gihan Fetih
Mahmoud El-Badry
Mohamed Fathy
P2860
P304
P356
10.1016/J.JSPS.2009.08.006
P577
2009-07-01T00:00:00Z